ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CI Cigna Group

339.67
-3.61 (-1.05%)
Last Updated: 17:57:05
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cigna Group NYSE:CI NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  -3.61 -1.05% 339.67 344.80 339.505 343.91 764,886 17:57:05

Insurers Accused of Discriminating Against People With HIV -- 2nd Update

29/05/2014 5:14pm

Dow Jones News


Cigna (NYSE:CI)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Cigna Charts.
By Louise Radnofsky 

Patient advocacy groups are using antidiscrimination provisions in the health-care law as the basis of a complaint against insurers they say are trying to avoid covering consumers with HIV and AIDS, in one of the first cases of its kind.

The National Health Law Program and the AIDS Institute submitted a complaint to the Department of Health and Human Services' Office of Civil Rights Thursday morning accusing four health insurers selling individual plans in Florida of discriminating against consumers with HIV in the way they designed their insurance benefits. The complaint names Coventry Health Care Inc., a unit of Aetna Inc., Cigna Corp., Humana Inc. and Preferred Medical, a plan based in Coral Gables, Fla.

The complaint says the four insurers put every HIV drug, even older generics, in the highest tier in their drug formularies, requiring patients to pay as much as 50% of the cost themselves.

HIV advocacy organizations have said the issue isn't specific to Florida and they believe a decision would influence plans across the country.

The health law bars insurers from charging customers more based on their medical history when it comes to setting premiums. The Wall Street Journal reported in December that HIV organizations believed some health insurers had found other ways to discourage people infected with HIV from signing up for their plans, such as requiring higher copayments for HIV drugs than they would for other prescriptions.

The two patient advocacy organizations are trying to challenge that practice by using another provision in the health law that bars any health program that receives federal funds from discriminating on the basis of "race, color, national origin, sex, age, or disability."

Wayne Turner, a staff attorney for the National Health Law Program, said the complaint appeared to be the first one that drew on the antidiscrimination provision to go after an insurance plan's benefit design.

A handful of different complaints filed with the Office of Civil Rights have cited the antidiscrimination provision to challenge other decisions by health insurers.

Alex Kepnes, a spokesman for Humana, and Karen Eldred, a spokeswoman for Cigna, both noted that their company's plans did cover HIV drugs.

Mr. Kepnes said Humana covered all HIV drugs except brand names when generics were available, and that the insurer considered most of them to be specialty drugs covered in the same category as treatments for conditions such as rheumatoid arthritis, multiple sclerosis and growth hormone disorders.

He pointed out that consumers wouldn't have to pay anything when filling their prescriptions after they had hit their maximum on out-of-pocket costs. Under the health law, no plans can have an out-of-pocket maximum higher than $6,350 for 2014.

Ms. Eldred said that Cigna covered all HIV drugs that were recognized as medically necessary and also offered consumers with HIV support managing their condition from a team of nurses, pharmacists and therapy support coordinators.

Matt Wiggin, a spokesman for Aetna, also said the exchange plans offered by Coventry provided access to HIV care that followed the latest Department of Health and Human Services guidelines and evidence based practices and that the company believed that Coventry's formularies met requirements under the health law.

Officials for Preferred Medical didn't immediately respond to requests for comment.

Melinda Beck contributed to this article.

Write to Louise Radnofsky at louise.radnofsky@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Cigna Chart

1 Year Cigna Chart

1 Month Cigna Chart

1 Month Cigna Chart

Your Recent History

Delayed Upgrade Clock